康德莱：公司具备研发、生产超细针头的技术和能力

Group 1 - The core viewpoint of the article is that Kangdelai (603987) has the technology and capability to research and produce ultra-fine needles, which are primarily applied in the fields of medical aesthetics and ophthalmology [1] Group 2 - The company engages with investors through an interactive platform, indicating a commitment to transparency and communication [1] - The focus on ultra-fine needles suggests a niche market strategy that could lead to potential growth opportunities in specialized medical applications [1]